Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
Authors
Keywords
-
Journal
DRUGS
Volume 78, Issue 10, Pages 1013-1024
Publisher
Springer Nature
Online
2018-06-18
DOI
10.1007/s40265-018-0934-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients
- (2018) Joseph J. Eron et al. AIDS
- Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial
- (2018) Chloe Orkin et al. Lancet HIV
- HIV-1 resistance rarely observed in subjects using darunavir once-daily regimens across clinical studies
- (2017) Erkki Lathouwers et al. HIV CLINICAL TRIALS
- Single-Tablet Regimens for the Treatment of HIV-1 Infection
- (2016) Jamielynn C. Sebaaly et al. ANNALS OF PHARMACOTHERAPY
- Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus
- (2016) Adrian S. Ray et al. ANTIVIRAL RESEARCH
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection
- (2016) Sarah L. Greig et al. DRUGS
- Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens
- (2016) D Armenia et al. HIV MEDICINE
- HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
- (2016) Kate El Bouzidi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In VitroVirology Profile of Tenofovir Alafenamide, a Novel Oral Prodrug of Tenofovir with Improved Antiviral Activity Compared to That of Tenofovir Disoproxil Fumarate
- (2015) Christian Callebaut et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial
- (2015) José R. Santos et al. CLINICAL INFECTIOUS DISEASES
- Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy
- (2015) Anthony Mills et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Metabolism and antiretroviral activity of tenofovir alafenamide in CD4+ T-cells and macrophages from demographically diverse donors
- (2014) Rujuta A Bam et al. ANTIVIRAL THERAPY
- Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients
- (2013) Erkki Lathouwers et al. ANTIVIRAL THERAPY
- Cobicistat: A Review of Its Use as a Pharmacokinetic Enhancer of Atazanavir and Darunavir in Patients with HIV-1 Infection
- (2013) Emma D. Deeks DRUGS
- Darunavir: A Review of Its Use in the Management of HIV-1 Infection
- (2013) Emma D. Deeks DRUGS
- Antiviral Activity, Safety, and Pharmacokinetics/Pharmacodynamics of Tenofovir Alafenamide as 10-Day Monotherapy in HIV-1–Positive Adults
- (2013) Peter J. Ruane et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Cobicistat: A New Boost for the Treatment of Human Immunodeficiency Virus Infection
- (2013) Bhavik M. Shah et al. PHARMACOTHERAPY
- Week 96 Efficacy, Virology and Safety of Darunavir/r Versus Lopinavir/r in Treatment-Experienced Patients in TITAN
- (2012) Denes Banhegyi et al. CURRENT HIV RESEARCH
- Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial
- (2012) C Orkin et al. HIV MEDICINE
- Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations
- (2010) Sonia Rodríguez-Nóvoa et al. AIDS
- Drug Resistance Mutations in HIV-Infected Patients in the Spanish Drug Resistance Database Failing Tipranavir and Darunavir Therapy
- (2010) E. Poveda et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cobicistat (GS-9350): A Potent and Selective Inhibitor of Human CYP3A as a Novel Pharmacoenhancer
- (2010) Lianhong Xu et al. ACS Medicinal Chemistry Letters
- Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials
- (2008) Sandra de Meyer et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started